Is CelSci CVM stock breaking key levels Investor Concern 20260420 Cartesian Therapeutics RNAC Stock Underweight Underperforming 20260420 Amplify AMPY Stock Is It Losing Momentum Quickly Q4 2025 Earnings Beat Estimates Is Progyny PGNY stock priced attractively Tick Up 20260420 IPDN Professional posts 27 percent year over year Q2 2023 quarterly revenue dip shares gain 203 percent